Lumithera announces initiation of eurolight registry study to evaluate long-term benefits of photobiomodulation (pbm) treatment using the valeda® light delivery system in patients with dry age-related macular degeneration (amd)

Seattle--(business wire)-- #dryamd--lumithera initiates eurolight registry study to evaluate long-term benefits of valeda® treatments in dry age-related macular degeneration patients.
AMD Ratings Summary
AMD Quant Ranking